Contract Research and API Production Onyx Scientific Achieves Record Year and Expands UK Site
Following the best performance in the company’s 15 year history, the contract research organisation (CRO) and small-scale API manufacturer Onyx Scientific is investing in an additional site located adjacent to its existing facility in North-East England.
Sunderland/UK – The additional space will primarily be used to increase Onyx’s laboratory facilities, GMP suites and allocate space for storage of GMP materials. The aim is to help clients accelerate candidates from discovery to production.
As part of the expansion initiative, Onyx Scientific has recruited several more chemists to support clients’ pre-clinical, development and early stage API manufacturing projects.
Denise Bowser, commercial director at Onyx Scientific, said: “It’s been a challenging few years for CROs across the industry but our team has continued to work hard to always exceed clients’ expectations, which has led to a very loyal customer base and regular repeat business.”
According to Bowser, Onyx Scientific remains committed to supporting drug developers across the globe with routine chemistry and overcoming early stage complex chemistry challenges to allow them to progress, scale-up and meet clinical deadline with robust lead candidates.
This latest venture follows investment last year to grow its GMP space following an increase in demand for its small scale API manufacturing services.
Established back in 2000, Onyx Scientific now provides clients with the production of API in up to 50–100 litres equipment under current GMP regulations, which fits with its earlier stage custom synthesis, lead optimisation and analytical services.
Denise added: “The decision to expand into an additional building has been driven by increased demand for GMP services as well as continuous flow projects and solid state chemistry, which has fully utilised our resources over the past twelve months.”